课题基金 / 基金详情

Investigating the Impact of Tumor Necrosis Factor Inhibitors on SARS-CoV-2 mRNA Vaccine-induced Immunity in Immunocompromised Patients with Immune-mediated Inflammatory Diseases

Investigating the Impact of Tumor Necrosis Factor Inhibitors on SARS-CoV-2 mRNA Vaccine-induced Immunity in Immunocompromised Patients with Immune-mediated Inflammatory Diseases
研究肿瘤坏死因子抑制剂对患有免疫介导炎症性疾病的免疫功能低下患者的 SARS-CoV-2 mRNA 疫苗诱导免疫的影响
批准号：
475681
负责人：
Cheung Michelle W
金额：
$7.65万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475681&lang=en
关键词：
Adaptive Immunity Bnt162b2 Sars-Cov-2 Vaccine Cite-Sequencing Covid-19 Immune-Mediated Inflammatory Diseases Immunocompromised Patients Mrna-1273 Sars-Cov-2 Vaccine Severe Acute Respiratory Syndrome Coronavirus 2 Tumor Necrosis Factor Inhibitors

项目摘要

项目成果

Cheung Michelle W的其他基金

相关文献

中文摘要
翻译
免疫功能低下的患者感染病毒的风险增加，感染后出现不良后果，包括重症监护病房入院和住院死亡。此外，它们还存在更长时间脱毒的风险，从而导致
英文摘要
Immunocompromised patients are at increased risk of viral infections and adverse outcomes following infection, including intensive care unit admission and in-hospital mortality. Further, they run the risk of shedding virus for longer, leading to increased
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Examining the Impacts of HIV Antiretrovirals on Maternal Immune Homeostasis
  • 批准号：
    466709
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2021
  • 负责人：
    Cheung Michelle W
  • 依托单位：
    University of Toronto